Woodline Partners LP
Institutional investor · Portfolio as of Q2 2022
Top Holdings792 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
STATE STREET SPDR S&P 500 ETF TRUST CL USD INC | 969,000 | $365.6M | 5.6% | — | — | — | Increased — |
ELI LILLY & CO | 496,003 | $160.8M | 2.5% | $287.45 | +8.96% | 11 qtrssince 2019-Q4 | Increased 84 |
STMICROELECTRONICS NV-NY SHS | 3.2M | $99.8M | 1.5% | $34.39 | -9.22% | 2 qtrssince 2022-Q1 | Increased 76 |
SKYWORKS SOLUTIONS INC | 955,660 | $88.5M | 1.4% | $84.31 | 0.00% | 1 qtr | New 68 |
BOSTON SCIENTIFIC CORP | 2.3M | $84.3M | 1.3% | $42.95 | -13.23% | 2 qtrssince 2022-Q1 | Increased 57 |
JOHNSON & JOHNSON | 464,666 | $82.5M | 1.3% | $143.00 | +11.50% | 9 qtrssince 2020-Q2 | Increased 68 |
ARROW ELECTRONICS INC | 629,372 | $70.5M | 1.1% | $120.63 | -8.48% | 11 qtrssince 2019-Q4 | Increased 54 |
ALLOGENE THERAPEUTICS INC | 5.9M | $66.8M | 1.0% | $13.29 | -12.09% | 9 qtrssince 2020-Q2 | Increased 75 |
BRISTOL-MYERS SQUIBB CO | 850,180 | $65.5M | 1.0% | $58.37 | +10.89% | 6 qtrssince 2021-Q1 | Increased 75 |
Legend Biotech Corp. Sponsored ADR | 1.2M | $64.4M | 1.0% | $46.03 | +18.27% | 5 qtrssince 2021-Q2 | Unchanged 0 |
JAZZ PHARMACEUTICALS PLC | 396,861 | $61.9M | 1.0% | $156.83 | -0.30% | 2 qtrssince 2022-Q1 | Increased 67 |
ASML HOLDING NV-NY REG SHS | 128,342 | $61.1M | 0.9% | $458.33 | 0.00% | 1 qtr | New 58 |
PALO ALTO NETWORKS INC | 121,119 | $59.8M | 0.9% | $81.97 | 0.00% | 1 qtr | New 57 |
MICROCHIP TECHNOLOGY INC | 974,938 | $56.6M | 0.9% | — | — | — | — |
MICROSOFT CORP | 216,551 | $55.6M | 0.9% | $252.93 | 0.00% | 1 qtr | New 57 |
ALKERMES PLC | 1.9M | $55.3M | 0.9% | $23.49 | +26.83% | 9 qtrssince 2020-Q2 | Increased 55 |
ACCENTURE PLC-CL A | 193,916 | $53.8M | 0.8% | $257.78 | 0.00% | 1 qtr | New 57 |
PALANTIR TECHNOLOGIES INC-A | 5.8M | $52.5M | 0.8% | $9.23 | 0.00% | 1 qtr | New 57 |
MEDTRONIC PLC | 577,581 | $51.8M | 0.8% | $81.22 | 0.00% | 1 qtr | New 57 |
MERCK & CO. INC. | 565,984 | $51.6M | 0.8% | $73.30 | +13.51% | 6 qtrssince 2021-Q1 | Decreased 0 |
Woodline Partners LP manages $6.5B across 792 positions as of Q2 2022. Top holdings: SPY (5.6%), LLY (2.5%), STM (1.5%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.
Active quarter - 237 new positions, 154 exits, 165 increased. Top move: LLY (INCREASED, conviction 84). Portfolio: $6.5B across 792 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer